Radiopharm Theranostics Limited (RADX) Gross margin 2023–2025
Radiopharm Theranostics Limited (RADX) gross margin by fiscal year — reported gross profit divided by reported revenue.
1.1%FY2025 · since FY2023: 100.0% → 1.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 1.1% | -98.9 pp |
| FY2024 | 100.0% | +0.0 pp |
| FY2023 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice